For US Healthcare Professionals

Welcome to
Special Exhibits

Delve into exhibits that explore the latest science on topics related to rheumatic diseases

Examine uveitis as a manifestation of SpA

AAU is a common manifestation of SpA, affecting as many as one-third of patients with the disease.1 Understanding the shared pathobiology of these conditions can help guide management.

AAU=acute anterior uveitis; SpA=spondyloarthritis.

Tour the uveitis exhibit

Explore the role of the IL-17 family in disease

The IL-17 family of cytokines consists of 6 structurally related signaling molecules (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F) that play important roles in the immune system.2 Tour an exhibit that examines each of these cytokines and their role in SpA and other immune-mediated inflammatory diseases.

Tour the IL-17 exhibit

Uncover the link between PSO and PsA

PSO and PsA are closely related conditions that fall under the umbrella of psoriatic disease.3 Discover how understanding the relationship between PSO and PsA can help guide management.

PsA=psoriatic arthritis; PSO=psoriasis.

Tour the
PSO & PsA exhibit

Discover the complexities of controlling inflammation

Recent research has turned to developing targeted therapies that address the complex interplay among cytokines in inflammatory conditions. This exhibit spotlights the amplifying role of IL-17 and considers how controlling inflammation requires a comprehensive clinical approach.

Tour the
inflammation exhibit

Examine the clinical implications of RF in RA

RF is an autoantibody found in many patients with RA and is a common biomarker of the disease.4 Journey through this exhibit that explores RF as a risk factor of RA, the role of RF in the pathobiology of RA, and the importance of considering RF levels when making clinical decisions.

RF=rheumatoid factor; RA=rheumatoid arthritis.

Tour the RF/RA exhibit

Investigate the relationship between IBD and arthritis

IBD-associated arthritis has complex manifestations that can significantly impact a patient’s quality of life. This exhibit explores the clinical manifestations, pathobiology, and burden of disease relating to IBD-SpA, and the importance of multidisciplinary collaboration.

IBD=inflammatory bowel disease.

Tour the IBD-SpA exhibit

  1. Hysa E, Cutolo CA, Gotelli E, et al. Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: an update. Eur J Clin Invest. 2021;51(8):e13572. doi:10.1111/eci.13572
  2. Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 2018;9:1682. doi:10.3389/fimmu.2018.01682
  3. Huo AP, Liao PL, Leong PY, et al. From psoriasis to psoriatic arthritis: epidemiological insights from a retrospective cohort study of 74,046 patients. Front Med (Lausanne). 2024;11:1419722. doi:10.3389/fmed.2024.1419722
  4. de Brito Rocha S, Baldo DC, Andrade LEC. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv Rheumatol. 2019;59(1):2. doi:10.1186/s42358-018-0042-8